Arcellx (ACLX) Total Non-Current Liabilities (2021 - 2025)

Arcellx's quarterly Total Non-Current Liabilities came in at $201.6 million in Q4 2025, down 18.67% year-on-year from $247.9 million in Q4 2024, and down 6.28% quarter-over-quarter from $215.1 million in Q3 2025.

Arcellx has reported Total Non-Current Liabilities for 4 years, with the latest figure at $201.6 million in Q4 2025.

  • For the quarter ending Q4 2025, Total Non-Current Liabilities fell 18.67% year-over-year to $201.6 million; the trailing twelve-month figure through Dec 2025 stood at $201.6 million (down 18.67% YoY), and the FY2025 full-year result was $201.6 million, down 18.67% from the prior year.
  • Total Non-Current Liabilities for Q4 2025 stood at $201.6 million, down from $215.1 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $267.7 million in Q1 2024, with the low at $16.7 million in Q4 2021.
  • Average Total Non-Current Liabilities over 4 years is $179.3 million, with a median of $226.9 million recorded in 2025.
  • Peak annual rise in Total Non-Current Liabilities reached 2.32% in 2025, while the deepest fall reached 19.38% in 2025.
  • Tracing ACLX's Total Non-Current Liabilities over 4 years: stood at $16.7 million in 2021, then soared by 204.22% to $50.9 million in 2022, then jumped by 386.86% to $247.9 million in 2024, then fell by 18.67% to $201.6 million in 2025.
  • The last three Total Non-Current Liabilities figures came in at $201.6 million (Q4 2025), $215.1 million (Q3 2025), and $226.9 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 201.64 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 201.64 Mn
Sep 30, 2025 215.14 Mn
Jun 30, 2025 226.86 Mn
Mar 31, 2025 227.74 Mn
Dec 31, 2024 247.94 Mn
Sep 30, 2024 266.84 Mn
Jun 30, 2024 232.24 Mn
Mar 31, 2024 267.65 Mn
Jun 30, 2022 50.93 Mn
Mar 31, 2022 18.90 Mn
Dec 31, 2021 16.74 Mn